XTNT vs ATEC vs NVCR vs OSPN vs GMED

For growth investors, Xtant Medical Holdings, Inc.

(XTNT) is the stronger pick with 28. 4% revenue growth year-over-year, versus 0. 0% for OneSpan Inc. (OSPN). OneSpan Inc. (OSPN) offers the better valuation at 6. 4x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate Alphatec Holdings, Inc. (ATEC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, OneSpan Inc.

(OSPN) is the cheapest at 6. 4x versus Globus Medical, Inc. at 21. 7x. On forward P/E, OneSpan Inc. is actually cheaper at 9. 9x.

Over the past 5 years, Globus Medical, Inc.

(GMED) delivered a total return of +16. 1%, compared to -91. 3% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: GMED returned +264. 4% versus XTNT's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Xtant Medical Holdings, Inc.

(XTNT) is the lower-risk stock at 0. 69β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately 220% more volatile than XTNT relative to the S&P 500. On balance sheet safety, OneSpan Inc. (OSPN) carries a lower debt/equity ratio of 2% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Xtant Medical Holdings, Inc.

(XTNT) is pulling ahead at 28. 4% versus 0. 0% for OneSpan Inc. (OSPN). On earnings-per-share growth, the picture is similar: Globus Medical, Inc. grew EPS 422. 7% year-over-year, compared to 15. 0% for Alphatec Holdings, Inc.. Over a 3-year CAGR, GMED leads at 42. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

OneSpan Inc.

(OSPN) is the more profitable company, earning 30. 0% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSPN leads at 20. 6% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OneSpan Inc.

(OSPN) trades at 9. 9x forward P/E versus 27. 1x for Alphatec Holdings, Inc. — 17. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATEC: 222. 6% to $25. 00.

In this comparison, OSPN (3.

9% yield) pays a dividend. XTNT, ATEC, NVCR, GMED do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, OneSpan Inc.

(OSPN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 3. 9% yield). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OSPN: -21. 7%, NVCR: +30. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XTNT (Healthcare) and ATEC (Healthcare) and NVCR (Healthcare) and OSPN (Technology) and GMED (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XTNT is a small-cap high-growth stock; ATEC is a small-cap high-growth stock; NVCR is a small-cap quality compounder stock; OSPN is a small-cap deep-value stock; GMED is a mid-cap high-growth stock. OSPN pays a dividend while XTNT, ATEC, NVCR, GMED do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.